µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© vm
y?8E6+
;&N=t64"
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© VX<jg #(
1.Co-stimulators (or co-stimulating molecules) HpX ;:/I
2.NK-kB Gec?
3.Immunoglobulin superfamily iE;D_m.>`O
4.antigen-presenting cell (APC) (
ndTEnpp
5.death domain 6?C|pO
6.CCR and CXCR n8
dJ6"L<"
7.Lectin (or mitogen) i:coNK)4
8.Clusters of differentiation, CD) 4%s6 d,6"
9.B7 family 7|/Ct;oO:
10.Cytotoxic T lymphocyte, CTL) |pA
11.IL-15 and IL-15 receptor (IL-15R) % >\v6ea
12.MHC restriction [7btoo|P]
13.Affinity-chromatography V4.&"0\n #
14.Cyctosprin A, CsA `pfZJ+
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 8NJxtT~0c~
BsJ
d*-:X
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© -sz
SA
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 eq!>~: #
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 0S%xm'|N
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ {|E'
y_7lSo8<
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© @|jLw($Ly
a
At<36{?
ÃâÒßѧרҵ£º WE*L=_zDS
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ h|T_
k
dx&!RK+
Ïû»¯ÄÚ¿Æ£º x/B1\U
I
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ p";5J+?(
e}u68|\EC
ѪҺ²¡Ñ§×¨Òµ£º 5uidi
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿